Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001741198-18-000001
Filing Date
2018-05-21
Accepted
2018-05-21 14:47:41
Documents
1
Effectiveness Date
2018-05-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5724
  Complete submission text file 0001741198-18-000001.txt   6752
Mailing Address 6208 FAYETTEVILLE ROAD #104 DURHAM NC 27713
Business Address 6208 FAYETTEVILLE ROAD #104 DURHAM NC 27713 919-599-4381
Emergo Therapeutics, Inc. (Filer) CIK: 0001741198 (see all company filings)

EIN.: 814088686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-312872 | Film No.: 18849260